What type of study is this?

This is a Systematic Review study.

December 8, 2025The Journal of Clinical Endocrinology & Metabolism

Biomarkers Driving Precision Medicine in Non-functioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature

View Full Paper

Ask AI

Bookmark

Increased β-catenin and Vimentin expression relate to epithelial–mesenchymal transition in pituitary tumors, unveiling critical biomarkers.
Epigenetic signatures revealed by DNA methylation indicate subtype-dependent molecular pathways across diverse tumor types.
Systematic review analysis utilized Scopus and Web of Science databases to compile 29 primary studies examining tumor heterogeneity.
Precision medicine applications demand multicenter validation of these promising biomarkers, highlighting the current exploratory nature.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Systematic review identifies key biomarkers and molecular pathways in non-functioning pituitary tumors, suggesting pathways for improved precision medicine.

Cite This Study

Tajuddin et al. (2025) studied this question.

synapsesocial.com/papers/693624ad4fa91c937236c6d9 https://doi.org/10.1210/clinem/dgaf650

View Full Paper

Ask AI

Bookmark

Implication

Systematic review identifies key biomarkers and molecular pathways in non-functioning pituitary tumors, suggesting pathways for improved precision medicine.

Biomarkers Driving Precision Medicine in Non-functioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature

Key Points

Discussion

Implication

Cite This Study

Biomarkers Driving Precision Medicine in Non-functioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider